Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Feb 12, 2024 9:12pm

221 Views

Post# 35876675

RE:RE:RE:RE:Pfizer

If and when we get BTD I believe we will have a deal that may fund a GBM trial or lung trial or we could go way out and it could be a trial for Covid cure. This should give us a better hint of who the suitor is. If AA happens we could be bought out before years end, and it could be a bidding war.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023